Analyze Diet
Equine veterinary journal2009; 41(6); 597-601; doi: 10.2746/042516409x407611

A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds.

Abstract: A glycogen synthase (GYS1) mutation has been described in horses with histopathological evidence of polysaccharide storage myopathy (PSSM) in the USA. It is unknown whether the same mutation is present in horses from the UK. Objective: To determine whether the GYS1 mutation occurs in UK horses with histopathological evidence of PSSM and exertional rhabdomyolysis. Objective: The R309H GYS1 mutation is present in a variety of UK horse breeds and that the mutation is commonly associated with exertional rhabdomyolysis. Methods: DNA was extracted from 47 muscle or blood samples from UK horses with histories of exertional rhabdomyolysis in which muscle biopsy diagnosis had been pursued. The proportions of GYS1 mutation positive cases were compared among histopathologically defined groups. In addition, breeds that carried the GYS1 mutation were identified from a total of 37 grade 2 (amylase-resistant) PSSM cases. Results: Of 47 horses with exertional rhabdomyolysis in which a muscle biopsy diagnosis was pursued, 10 (21%) carried the GYS1 mutation. The mutation was only found in horses with grade 2 PSSM (i.e. not in horses with normal, idiopathic myopathy or grade 1 PSSM biopsy samples). In total, the GYS1 mutation was found in 24/37 (65%) of grade 2 PSSM cases. A variety of breeds, including Quarter Horse, Appaloosa, Warmblood, Connemara-cross, Cob, Polo Pony and Thoroughbred cross carried the mutation. Conclusions: The GYS1 mutation is an important cause of exertional rhabdomyolysis of UK horse breeds but does not account for all forms of PSSM. Conclusions: Genotyping is recommended in cases of exertional rhabdomyolysis, prior to or in combination with, muscle biopsy. However a significant proportion of horses with histopathological evidence of PSSM and/or exertional rhabdomyolysis have different diseases.
Publication Date: 2009-10-07 PubMed ID: 19803057DOI: 10.2746/042516409x407611Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses a study conducted to determine if a specific mutation, known as the glycogen synthase (GYS1) mutation, associated with a disease known as polysaccharide storage myopathy (PSSM) and exertional rhabdomyolysis, is present in horses from the UK. The study found that the mutation is indeed present in a variety of UK horse breeds.

Objective and Methodology

The main objective of the study was to investigate whether the GYS1 mutation, previously found in horses with PSSM in the United States, was also present in UK horses showing similar symptoms. An additional objective was to confirm if this mutation is commonly associated with exertional rhabdomyolysis, a muscle disease related to exercise.

  • The researchers conducted their study by extracting DNA from 47 samples of muscle or blood from UK horses that had histories of exertional rhabdomyolysis and had been biopsied for diagnosis.
  • The percentage of horses testing positive for the GYS1 mutation was compared among different groups categorized by their histopathological characteristics.
  • The study also identified the breeds carrying the GYS1 mutation, from a total of 37 horses diagnosed with grade 2 (amylase-resistant) PSSM.

Results

  • Out of 47 horse samples, 10 (i.e. 21%) were found to carry the GYS1 mutation. The study confirmed that this mutation was only present in horses with a diagnosis of grade 2 PSSM, and not in horses with normal or other types of myopathy.
  • The total prevalence of the GYS1 mutation was found to be high—65%—among horses with grade 2 PSSM.
  • A range of breeds, such as Quarter Horse, Appaloosa, Warmblood, Connemara-cross, Cob, Polo Pony and Thoroughbred cross were identified as carrying the mutation.

Conclusions

  • The GYS1 mutation is a significant cause of exertional rhabdomyolysis in UK horse breeds. However, it does not account for all forms of PSSM.
  • Genotyping—the process of determining differences in the genetic make-up of an individual—is recommended for cases of exertional rhabdomyolysis, either before or in combination with muscle biopsy. However, it is important to note that a significant proportion of horses showing histopathological evidence of PSSM and/or exertional rhabdomyolysis have different diseases.

Cite This Article

APA
Stanley RL, McCue ME, Valberg SJ, Mickelson JR, Mayhew IG, McGowan C, Hahn CN, Patterson-Kane JC, Piercy RJ. (2009). A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds. Equine Vet J, 41(6), 597-601. https://doi.org/10.2746/042516409x407611

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 41
Issue: 6
Pages: 597-601

Researcher Affiliations

Stanley, R L
  • Comparative Neuromuscular Diseases Laboratory, Department of Veterinary Clinical Sciences, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire AL9 7TA, UK.
McCue, M E
    Valberg, S J
      Mickelson, J R
        Mayhew, I G
          McGowan, C
            Hahn, C N
              Patterson-Kane, J C
                Piercy, R J

                  MeSH Terms

                  • Animals
                  • Female
                  • Gene Expression Regulation, Enzymologic / physiology
                  • Genetic Predisposition to Disease
                  • Glycogen Storage Disease / genetics
                  • Glycogen Storage Disease / metabolism
                  • Glycogen Storage Disease / veterinary
                  • Glycogen Synthase / genetics
                  • Glycogen Synthase / metabolism
                  • Horse Diseases / genetics
                  • Horses
                  • Male
                  • Muscle, Skeletal / pathology
                  • Polysaccharides / metabolism
                  • Retrospective Studies
                  • Rhabdomyolysis / genetics
                  • Rhabdomyolysis / veterinary
                  • United Kingdom

                  Citations

                  This article has been cited 9 times.
                  1. Lindsay-McGee V, Massey C, Li YT, Clark EL, Psifidi A, Piercy RJ. Characterisation of phenotypic patterns in equine exercise-associated myopathies. Equine Vet J 2025 Mar;57(2):347-361.
                    doi: 10.1111/evj.14128pubmed: 38965932google scholar: lookup
                  2. Schumacher A, Gehlen H. Health of Polo Horses. Animals (Basel) 2024 Jun 8;14(12).
                    doi: 10.3390/ani14121735pubmed: 38929354google scholar: lookup
                  3. Buckley P, Buckley DJ, Freire R, Hughes KJ. Pre-race and race management impacts serum muscle enzyme activity in Australian endurance horses. Equine Vet J 2022 Sep;54(5):895-904.
                    doi: 10.1111/evj.13519pubmed: 34601756google scholar: lookup
                  4. Williams ZJ, Bertels M, Valberg SJ. Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy. PLoS One 2018;13(9):e0203467.
                    doi: 10.1371/journal.pone.0203467pubmed: 30183782google scholar: lookup
                  5. Tosi I, Art T, Cassart D, Farnir F, Ceusters J, Serteyn D, Lemieux H, Votion DM. Altered mitochondrial oxidative phosphorylation capacity in horses suffering from polysaccharide storage myopathy. J Bioenerg Biomembr 2018 Oct;50(5):379-390.
                    doi: 10.1007/s10863-018-9768-6pubmed: 30143916google scholar: lookup
                  6. Maile CA, Hingst JR, Mahalingan KK, O'Reilly AO, Cleasby ME, Mickelson JR, McCue ME, Anderson SM, Hurley TD, Wojtaszewski JFP, Piercy RJ. A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase. Biochim Biophys Acta Gen Subj 2017 Jan;1861(1 Pt A):3388-3398.
                    doi: 10.1016/j.bbagen.2016.08.021pubmed: 27592162google scholar: lookup
                  7. McCoy AM, Schaefer R, Petersen JL, Morrell PL, Slamka MA, Mickelson JR, Valberg SJ, McCue ME. Evidence of positive selection for a glycogen synthase (GYS1) mutation in domestic horse populations. J Hered 2014 Mar-Apr;105(2):163-72.
                    doi: 10.1093/jhered/est075pubmed: 24215078google scholar: lookup
                  8. Naylor RJ, Livesey L, Schumacher J, Henke N, Massey C, Brock KV, Fernandez-Fuente M, Piercy RJ. Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1). PLoS One 2012;7(7):e42317.
                    doi: 10.1371/journal.pone.0042317pubmed: 22860112google scholar: lookup
                  9. Isgren CM, Upjohn MM, Fernandez-Fuente M, Massey C, Pollott G, Verheyen KL, Piercy RJ. Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance. PLoS One 2010 Jul 14;5(7):e11594.
                    doi: 10.1371/journal.pone.0011594pubmed: 20644724google scholar: lookup